Polyphenols are bioactive molecules that are used in therapeutics. Polyphenol hydroxylation and glycosylation have been shown to increase their bioavailability, solubility, bioactivity, and stability for use in various applications. Ortho-hydroxylation of polyphenols using tyrosinase allows high selectivity and yield without requiring a cofactor, while meta- and para-hydroxylation of polyphenols are mediated by site-specific hydroxylases and cytochrome P450s, although these processes are somewhat rare. O-glycosylation of polyphenols proceeds further after hydroxylation. The O-glycosylation reaction typically requires nucleotide diphosphate (NDP) sugar. However, amylosucrase (AS) has emerged as a promising enzyme for polyphenol glycosylation in large-scale production without requiring NDP-sugar. Overall, this review describes recent findings on the enzymatic mechanisms, enzyme engineering, and applications of enzymatic reactions.
This research was supported by the Korea Initiative for Fostering the University of Research and Innovation Program of the National Research Foundation (NRF) funded by the Korean government Ministry of Science and ICT (MSIT) (No. NRF- 2020M3H1A1073304 , 2021R1A2CI007519 ), the Korea Medical Device Development Fund grant funded by the Ministry of Science and information and communication technology (ICT), the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety (KMDF_PR_ 20200901_0151 ), and a Regenerative Medicine Korean Fund for Regenerative Medicine (KFRM) grant funded by the Ministry of Science and ICT , Ministry of Health & Welfare ( 21A0301L1 ) of the Republic of Korea, and the R&D program of Ministry of Trade, Industry and Energy/Korea Evaluation Institute of Industrial Technology (MOTIE/KEIT) (grant number: 20014350 ).